HomeVIRP • EPA
add
Virbac SA
Previous close
€319.50
Day range
€317.50 - €323.50
Year range
€276.50 - €400.00
Market cap
2.73B EUR
Avg Volume
4.74K
P/E ratio
-
Dividend yield
0.41%
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 351.47M | 15.15% |
Operating expense | 166.89M | 13.08% |
Net income | 47.33M | 26.16% |
Net profit margin | 13.47 | 9.60% |
Earnings per share | — | — |
EBITDA | 84.35M | 33.61% |
Effective tax rate | 33.28% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 158.64M | -29.27% |
Total assets | 1.80B | 26.44% |
Total liabilities | 801.99M | 53.43% |
Total equity | 994.24M | — |
Shares outstanding | 8.37M | — |
Price to book | 2.69 | — |
Return on assets | 10.37% | — |
Return on capital | 13.30% | — |
Cash Flow
Net change in cash
(EUR) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 47.33M | 26.16% |
Cash from operations | 18.30M | 121.37% |
Cash from investing | -183.62M | -1,040.48% |
Cash from financing | 127.14M | 546.08% |
Net change in cash | -38.19M | -422.43% |
Free cash flow | 44.04M | 32.67% |
About
Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick.
The company is the 6th the largest veterinarian pharmaceutical group with a turnover of 1,247 million euros in 2023. The company is a limited company with a board Euronext Paris stock exchange - compartiment A and is part of the reference index: SBF 120, and eligible SRD, PEA and PEA-PME. Wikipedia
Founded
1968
Headquarters
Website
Employees
5,459